August 13, 2013 - Speech by the President of the Republic, Dilma Rousseff, at the inauguration ceremony of the new biotechnology and cytostatics factory and the expansion of the pharmaceutical complex of the Cristália Industrial Complex.

Brazil Dilma Rousseff · President of Brazil

13 August 2013 · Inauguration ceremony of the new biotechnology and cytostatics factory and expansion of the pharmaceutical complex of the Cristália Industrial Complex · Cristália Industrial Complex, Itapira

Context
Rousseff addressed workers and officials at Cristália's industrial complex in Itapira, São Paulo, inaugurating a new biotechnology factory and pharmaceutical expansion on August 13, 2013.
Main themes
Pharmaceutical industry development, biotechnology expansion, Brazilian industrial sovereignty, health sector investment, research and development, innovation policy, Brazil Maior Plan, domestic medicine production, public-private partnership, active ingredient production
Duration
~18 min
61st percentile
Words
2,195
61st percentile
Sentences
93
59th percentile
Readability
48
56th percentile
Grade
12.4
50th percentile
Syntax
3.15
66th percentile
Vocabulary
2.34
82nd percentile

Translated from Portuguese

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 34%33%
  • Ceremonial 32%31%
  • Social 29%28%
  • Geopolitical 2%2%
  • Institutional 2%2%
  • Technological 1%1%
  • Environmental 0%0%
  • Not in focus 2%

93 sentences in 37 paragraphs

Good afternoon everyone. I would like to start by greeting the workers of Cristália, its directors, and all the employees. This is a celebration, a commemoration that we owe to you, and one impressive thing is how most of you... I will say, how all of you are young; it is something very important when we see that your strength, which is youth, with the water of Cristália, as Ogari mentioned, truly creates this capacity to realize dreams.

I would first like to greet our governor, Geraldo Alckmin, the governor of São Paulo.

I would like to greet the mayor of Itapira, José Natalino Paganini, and on his behalf, I greet all the mayors present here.

I would like to extend a special greeting to the widow of Cristália's co-founder, João Stevanato, Mrs. Íris Stevanato.

I would like to greet Mr. Ogari de Castro Pacheco, president of the Cristália Industrial Complex, and also his wife, Mrs. Maria Adelaide Pacheco.

I would like to greet the ministers of state who are accompanying me on this trip, all three ministers involved in this productive development process that we are witnessing here, which is Cristália. First, Minister Alexandre Padilha, of Health; then Minister Fernando Pimentel, of the Ministry of Development, Industry and Foreign Trade, responsible for the Brazil Maior Plan; and our Minister of Science, Technology and Innovation, Marco Antonio Raupp, who is responsible for scientific and technological development and innovation in our country.

I would like to greet the federal deputies: Nilton Lima and Paulo Freire.

I would like to greet the Secretary of Science and Technology of the Ministry of Health, Carlos Gadelha.

I would like to greet the Secretary of State for Health, Giovanni Guido Cerri.

I would like to greet the state deputies Antônio Mentor and Barros Munhoz.

I would like to greet the councilman Carlos Sartori, president of the City Council of Itapira.

I would like to greet the partners in this venture: Glauco Arbix, president of Finep; Paulo Gadelha, president of Fiocruz; Dirceu Barbano, director-president of Anvisa; Luiz Santini, general director of the National Cancer Institute (INCA).

I would like to greet Mr. Odair Antonio Bortolozzo, president of the Chemical Workers' Union.

And I would like to greet the ladies and gentlemen journalists, photographers, and cameramen.

My first words are to congratulate Cristália for this expansion plant of the pharmaceutical industry and this biotechnology plant for biopharmaceuticals. And with this, to acknowledge that Brazil has an industrial complex of this size that we see here, this industrial complex of Cristália, in an area that is strategic for our country, which is the area of medicines, and that requires, we know, so much technology. And this means that we are taking a step towards the creation, in Brazil, of a true hub in the health industrial complex.

Cristália is this industrial complex, and I think it must be said “industrial complex”; I learned this when visiting the plant. In fact, Cristália is a 100% Brazilian industrial complex, and this fills us with pride. It fills us with pride because it will provide medicines and raw materials for our country, and it will also export medicines and raw materials.

This new plant of the biotechnology division demonstrates our country's capacity to operate at the frontier of knowledge. And at the same time, this affirmation of the expansion of the pharmaceutical industry shows that we have all the conditions to qualify ourselves as major producing countries.

I consider it very important a fact that I will emphasize, which is that Cristália invests part of its revenue in research in partnerships with universities and research centers. Why do I emphasize this? Because around the world, companies that grow do this, they invest a part of their revenue in research and development.

And I would like to remind you that recently American statistical agencies changed the concept of investment in GDP, incorporating innovation as such an important item to configure gross fixed capital formation or, rather, the investment rate, based on two things: heavy and light civil construction, machinery and equipment; and innovation. In other words, value is attributed to patents, value is attributed to innovation, because in fact this is the frontier, both economically and in terms of knowledge, of what is new in this 21st century.

I was extremely impressed by the fact that while we, as a country, still depend 14%, in fact, we only produce 14% and the rest we depend on imports, with the fact that Cristália produces 50% of the active ingredients it uses in the production chain here in this complex. It is precisely for this reason that I consider Cristália to be one of the companies that demonstrates itself as a great partner in our productive development policy in the health area defined in the Brazil Maior Plan, launched at the beginning of the government by the Ministry of Industry and Commerce. We believe that today Brazil must take this step.

So, a productive development policy means that we must empower ourselves to produce in Brazil what we are capable of producing. This does not imply any xenophobia or a policy of non-importation stricto sensu or a policy of ‘we simply do not import anymore’. But it implies Brazil's capacity to combine its internal production conditions with the importation of part of what interests us. Not because this was imposed on us, not because we submitted to being a subordinate part of the production chain. But because we choose to do so when it suits us. I therefore consider this partnership very important. And recognizing that Cristália has 31, mind you, 31 partnerships with the Ministry of Health and public laboratories also fills me with pride.

My presence at this inauguration has a purpose, which is to reaffirm that the partnership with Cristália is strategic for Brazil; to reaffirm the government's commitment to all the companies, many of which are present here, in the health complex area, companies that research, that generate innovation, that invest, that create jobs and generate income in Brazil.

We want, business leaders, to expand these partnerships with all national and international companies that accept the challenge of producing here in Brazil. This is a strategic political choice. We are using the purchasing power of the Brazilian state to stimulate the national industry. You see, we are using the purchasing power of the Brazilian state, which is one of the largest buyers of medicines, to stimulate the national industry, to support technology transfer and expand the generation of innovations.

Finep – Finep, here is our president of Finep – and BNDES, also present here, also participate in this effort, in a strategic way. Finep, on one hand, through subsidies for research – it is important to say this – subsidies for research, technological development, and innovation, because Finep subsidizes research, ensures that research in Brazil can develop, will develop, and must develop, and the state is a partner in this by subsidizing, providing a subsidy for this research. BNDES, in turn, with its financing lines, helps to develop production, makes resources available for production to develop.

The Ministry of Health has the advantage of seeing the capacity to distribute the necessary medicines for the health care of the population increased, whether those for continuous use, such as those for diabetes, hypertension, and asthma, or those of high cost, such as antiretrovirals and oncology drugs.

I would like to highlight that strengthening the oncology care policy is a commitment we have pursued since the beginning of my government. In fact, we launched, back in 2011, programs to expand the fight against breast and cervical cancer and to reduce the suffering that these diseases bring to thousands of Brazilian women. Starting next year, we will – as Padilha said – vaccinate girls aged 10 and 11 against the HPV virus, the main cause of cervical cancer.

I would like to say here, my friends, that supported by the commitment to purchase by the SUS, the companies in this area – and here I speak, especially, of Cristália – can prioritize the manufacture of oncology medicines necessary for the treatment of leukemia, cervical and breast cancers, gastrointestinal tumors, to give a few examples.

And I believe we can affirm one thing. With these policies, everyone wins. Companies win, for example, because they begin to have a horizon with lower risk to make their investments. We, the Brazilian people, Brazil becomes less dependent on the external market in relation to strategic medicines. The SUS can offer medicines to more Brazilians.

Yes, I won, you saw, and I think it is extremely symbolic, I received here from a sculptor, if I am not mistaken, German, a representation of what partnership is, and here we have a partnership. We have a partnership with the state government, we have a partnership with the companies, Finep comes in, BNDES comes in, and the Ministry of Health comes in. And this is the type of action in which everyone cooperates, everyone wins, and who benefits the most is our people, is our country.

And I would like to tell you: innovation is something, here in these buildings, is something different from other innovations because here in this area, innovation in the health sector can represent the cure of a disease, can represent a gain in life, a gain in life span, a blessing for millions of families who worry about their relatives, their friends, and this means a lot in people's lives. I am sure that this fact touches all of us when we see the quality standard adopted here. It gives us the certainty that Brazil is on the right track. And, above all, it gives us another certainty: it gives the certainty that when you have the application of technology in favor of the whole Brazilian people, we all win.

I would also like to say, because we are living in this moment, that quality health also requires, it also requires the existence not only of medicines, of quality medicines, of the latest generation, but also the importance of having health equipment, hospitals, health posts, UPAs, and also doctors to make diagnoses and provide prescriptions. Without doctors, there is no quality health. And this is the challenge we have to face with the Mais Médicos Program.

I mention it because it is very timely to talk about this issue when we are here inaugurating this System. We have the urgent challenge of eliminating the care gaps that exist in Brazil. In 700 municipalities, you know, there is not a single doctor; in 1,900 there are fewer than one doctor per three thousand inhabitants. And the federal government is aware that we need to increase the number of professionals in the peripheries of large cities, in the interior of the country, and in the North and Northeast regions.

We are acting on two fronts simultaneously. The first front is to increase the training of professionals in our country. We had already authorized the creation of 2,400 new places in medical courses. And now we are opening, from now until 2017, more 11,400 places for medical graduates, and 12,000 for residencies, notably in those areas most needed, such as pediatrics, cancer treatment, heart treatment, to name a few.

Today we have a reality: it is necessary to wait some time until these professionals graduate. But we know that these doctors are needed in Brazil now. Therefore, despite prioritizing doctors trained here in Brazil, doctors who have their training in the medical schools of our country, when there are vacancies that are not filled by any doctor trained here, we will hire professionals trained abroad, who will work only in the Unified Health System monitored by federal universities.

I want to share some numbers with you. In the first month of adherence to this project, 3,511 municipalities registered and requested 15,470 doctors. Here in the state of São Paulo, 309 municipalities joined, out of a total of 645 municipalities, and requested 2,197 doctors. These numbers show that the lack of doctors is a national problem that affects even the richest state in our country. I want to make it clear to all of you, to the Brazilian population, that there will be no lack of political will from my government to tackle this problem.

Finally, I would like to emphasize that we must value our winning stories, such as this system here at Cristália. I would like to conclude by first congratulating all of you who make the day-to-day of this industrial complex. But I wanted to, and I think this is something Brazil should always do, which is to value experiences and men and women who have a fundamental contribution in different sectors in our country. And now I would like to honor a valuable Brazilian who shows and proves that he has always believed in our country. I would like to honor Dr. Ogari Pacheco.

Thank you very much. And a kiss to each of the young men and women who make this System that is the Cristália System. And indeed, Dr. Ogari, I believe that the waters inspire dreams and realize dreams.